PETER DOMINICK: Open Payments
NPI 1639644198 · ALBEMARLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,029 in 119 payments from 15 companies in 2025. Trend: 2023 $2,516 · 2024 $2,205 · 2025 $2,029
Food & beverage: $1,836Education: $193
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $428 |
| GENZYME CORPORATION | 12 | $313 |
| UCB, Inc. | 14 | $216 |
| ABBVIE INC. | 13 | $203 |
| PFIZER INC. | 17 | $156 |
| Regeneron Healthcare Solutions, Inc. | 8 | $144 |
| Lilly USA, LLC | 9 | $140 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Organon LLC | 5 | $81 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, CIBINQO, TALTZ, ILUMYA, VTAMA.
Industry payments across NC — which companies pay providers there.
